Family offices made 52 private-company investments in August as biotech rebounds

Verifying
  • Family offices made 52 direct investments in private companies during August.
  • Biotech startups received about 20% of August's family-office investment transactions.
  • U.S. and European biopharma startups raised $12.6 billion in the first half of 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.